Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

RPR describes tachykinin NK1 antagonists

July 26, 1996

BMDB shows antinociceptive activity in mouse model

July 26, 1996

Trial results described for methylphenidate in head injury patients

July 19, 1996

Adenosine A1 antagonists described by German universities

July 19, 1996

Muscarinic cholinergic ligands described by Novo Nordisk

July 19, 1996

Athena Neuroscience's BotB successfully completes phase II in cervical dystonia

July 19, 1996

GDNF vital for kidney and enteric nervous system development

July 19, 1996

Athena Neurosciences acquires worldwide rights to new formulation of Carbatrol

July 19, 1996

Abbott's Serlect receives FDA marketing approval

July 19, 1996

Neurogen reveals D3/D4 receptor-selective compounds

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...